Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideWSTWest Pharmaceutical Services
FinDog View：Neutral
| Metric | ABBV | WST |
|---|
| Close | 262.51 | 362.01 |
| Market Cap | $464B | $23.9B |
| 1M | +4.87% | +4.44% |
| P/E (TTM) | 73.7 | 43.1 |
| Forward P/E | 16.8 | 36.0 |
| P/E 5-Yr Percentile | 51 | 49 |
| P/S | 7.2 | 7.3 |
| P/B | — | 8.2 |
| Dividend Yield | 4.47% | 0.33% |
| Latest Quarter Revenue | $17.0B | $872M |
| Revenue YoY | +10.2% | +13.8% |
| Gross Margin | 74.7% | 37.7% |
| Latest Quarter EPS | 2.03 | 2.15 |
| Avg Post-Earnings Move | ±1.7% | ±3.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 1 / 1 |
| Shareholder Yield | 2.91% | 2.16% |
| 90-Day Net Insider Buying | −$8.2M | −$5.4M |
ABBV · Revenue, Last 8 Quarters ($B)
WST · Revenue, Last 8 Quarters ($B)
